BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $42.00 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2023-11-01
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-09-30 was $42.00M, a 64.71% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-06-30 was $58.00M, a 64.85% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2023-03-31 was $10.00M, a 71.43% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2022-12-31 was -$105.00M, a 503.85% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was $214.00M, a 2.88% increase from fiscal 2021.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2021 was $208.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2020 was -$77.00M, a 166.38% decline from fiscal 2019.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2019 was $116.00M, a 20.83% increase from fiscal 2018.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2023-09-30 | $42.00M 10-Q · filed 2023-11-01 | $100.00M derived: sum of 2 quarters · filed 2023-11-01 | $109.00M 10-Q · filed 2023-11-01 | $5.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | $58.00M 10-Q · filed 2023-08-03 | $67.00M 10-Q · filed 2023-08-03 | -$37.00M derived: sum of 3 quarters · filed 2023-08-03 | $82.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-03-31 | $10.00M 10-Q · filed 2023-05-04 | -$95.00M derived: sum of 2 quarters · filed 2023-05-04 | $24.00M derived: sum of 3 quarters · filed 2023-11-01 | $189.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-12-31 | -$105.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $14.00M derived: sum of 2 quarters · filed 2023-11-01 | $179.00M derived: sum of 3 quarters · filed 2023-11-01 | $214.00M 10-K · filed 2023-02-23 |
| 2022-09-30 | $119.00M 10-Q · filed 2023-11-01 | $284.00M derived: sum of 2 quarters · filed 2023-11-01 | $319.00M 10-Q · filed 2023-11-01 | $345.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $165.00M 10-Q · filed 2023-08-03 | $200.00M 10-Q · filed 2023-08-03 | $226.00M derived: sum of 3 quarters · filed 2023-08-03 | $287.00M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $35.00M 10-Q · filed 2023-05-04 | $61.00M derived: sum of 2 quarters · filed 2023-05-04 | $122.00M derived: sum of 3 quarters · filed 2023-05-04 | $110.00M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $87.00M derived: sum of 2 quarters · filed 2023-02-23 | $75.00M derived: sum of 3 quarters · filed 2023-02-23 | $208.00M 10-K · filed 2023-02-23 |
| 2021-09-30 | $61.00M 10-Q · filed 2022-11-03 | $49.00M derived: sum of 2 quarters · filed 2022-11-03 | $182.00M 10-Q · filed 2022-11-03 | $69.00M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$12.00M 10-Q · filed 2022-08-04 | $121.00M 10-Q · filed 2022-08-04 | $8.00M derived: sum of 3 quarters · filed 2022-08-04 | -$42.00M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $133.00M 10-Q · filed 2022-05-05 | $20.00M derived: sum of 2 quarters · filed 2022-05-05 | -$30.00M derived: sum of 3 quarters · filed 2022-05-05 | -$36.00M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$113.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$163.00M derived: sum of 2 quarters · filed 2022-02-23 | -$169.00M derived: sum of 3 quarters · filed 2022-02-23 | -$77.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | -$50.00M 10-Q · filed 2021-11-04 | -$56.00M derived: sum of 2 quarters · filed 2021-11-04 | $36.00M 10-Q · filed 2021-11-04 | $16.00M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$6.00M 10-Q · filed 2021-08-06 | $86.00M 10-Q · filed 2021-08-06 | $66.00M derived: sum of 3 quarters · filed 2021-08-06 | $144.00M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $92.00M 10-Q · filed 2021-05-06 | $72.00M derived: sum of 2 quarters · filed 2021-05-06 | $150.00M derived: sum of 3 quarters · filed 2021-05-06 | $152.00M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $58.00M derived: sum of 2 quarters · filed 2021-02-23 | $60.00M derived: sum of 3 quarters · filed 2021-02-23 | $116.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | $78.00M 10-Q · filed 2020-11-05 | $80.00M derived: sum of 2 quarters · filed 2020-11-05 | $136.00M 10-Q · filed 2020-11-05 | $127.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.00M 10-Q · filed 2020-08-05 | $58.00M 10-Q · filed 2020-08-05 | $49.00M derived: sum of 3 quarters · filed 2020-08-05 | $94.00M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $56.00M 10-Q · filed 2020-05-06 | $47.00M derived: sum of 2 quarters · filed 2020-05-06 | $92.00M derived: sum of 3 quarters · filed 2020-05-06 | $243.00M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $36.00M derived: sum of 2 quarters · filed 2020-02-25 | $187.00M derived: sum of 3 quarters · filed 2020-02-25 | $96.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $45.00M 10-Q · filed 2019-11-05 | $196.00M derived: sum of 2 quarters · filed 2019-11-05 | $105.00M 10-Q · filed 2019-11-05 | $96.00M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $151.00M 10-Q · filed 2019-07-30 | $59.00M 10-Q · filed 2019-07-30 | $51.00M derived: sum of 3 quarters · filed 2019-07-30 | $36.00M derived: sum of 4 quarters · filed 2019-07-30 |
| 2018-03-31 | -$91.00M 10-Q · filed 2019-04-29 | -$100.00M derived: sum of 2 quarters · filed 2019-04-29 | -$115.00M derived: sum of 3 quarters · filed 2019-04-29 | -$119.00M derived: sum of 4 quarters · filed 2019-04-29 |
| 2017-12-31 | -$9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$24.00M derived: sum of 2 quarters · filed 2019-02-19 | -$28.00M derived: sum of 3 quarters · filed 2019-02-19 | -$65.00M 10-K · filed 2019-02-19 |
| 2017-09-30 | -$15.00M 10-Q · filed 2018-10-29 | -$19.00M derived: sum of 2 quarters · filed 2018-10-29 | -$56.00M 10-Q · filed 2018-10-29 | |
| 2017-06-30 | -$4.00M 10-Q · filed 2018-07-31 | -$41.00M 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |